Trial Profile
Clinical and virologic assesment of three therapeutic options: antiviral Ganciclovir 0.15% ophthalmic gel, povidone-iodine 0.4% and physiologic saline solution 0.9% used in patients with acute adenoviral conjuntivitis.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Jul 2015
Price :
$35
*
At a glance
- Drugs Ganciclovir (Primary)
- Indications Infectious conjunctivitis
- Focus Therapeutic Use
- 01 Jul 2015 New trial record